NEW YORK(GenomeWeb) – Wafergen Biosystems today filed a shelf registration to offer up to $30 million of securities from time to time. 

Wafergen President and CEO Ivan Trifunovich told GenomeWeb that there are no imminent financing plans. In August, the firm raised $20 million in gross proceeds through an offering of its common stock and warrants.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Berkeley researchers have engineered yeast to make the molecule behind the hoppy taste of beer, Quartz reports.

King's College London researchers examine the influence of school type and genetics on academic achievement.

FiveThirtyEight writes that most who take a direct-to-consumer BRCA1/2 genetic test won't learn much from it.

In Science this week: early life experience influence somatic variation in the genome, and more.